Impact of Adapted Aesthetic Onco in Patients With Upper Aerodigestive Tract Cancer During Their Management
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Francois Baclesse
About this trial
Treatment for cancers of the pharyngolarynx is mutilating, with major consequences for patients' lives in terms of physical and functional after-effects. The psycho-social consequences are also significant, notably the metamorphosis of identity linked to the disease and its treatment, which alters the patient's self-image.
Initial feedback from patients who have been able to benefit from adapted oncoesthetics (OEA) is overwhelmingly positive.
This study will assess the feasibility of oncoesthetics and describe any obstacles.
Eligibility criteria
Qualifiers
Patient aged 18 or over
Neoplastic location: oropharynx, oral cavity, hypopharynx, larynx, nasal cavity, salivary glands, cavum, sinus.
Patient due to start oncological treatment (recurrence authorized)
Patient fluent in French.
Disqualifiers
Breast-feeding or pregnant patient
Any associated medical or psychological condition that could compromise the patient's ability to participate in the study
Patient deprived of liberty, under guardianship, or subject to a legal protection measure or unable to express their consent.
Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons.
Trial design
Treatments tested in this trial
- Adapted Onco-Esthetics sessions
Treatment groups
55 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov